Clinical trials in Bouches-du-Rhône

2 clinical trials in Bouches-du-Rhône, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in FranceEssaisCliniques.fr

Bouches-du-Rhône at a glance

clinical trials

Not yet recruiting0
Paediatric trials0
Research sites0

Quick filters

2 trials in Bouches-du-Rhône

Open in trial search

Type 1 diabetes mellitus

Recruiting

A Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes

Registered drug

A Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes

Registered drug

France

Participants:0–17 years · 18–64 years
Substances:Baricitinib
Sponsor:Eli Lilly & Co.

Contact Research Centre

Medullary thyroid cancer

Not recruiting

Study Comparing Selpercatinib, Cabozantinib, and Vandetanib for Patients with Advanced RET-Mutant Medullary Thyroid Cancer

Registered drugNo placebo

Study Comparing Selpercatinib, Cabozantinib, and Vandetanib for Patients with Advanced RET-Mutant Medullary Thyroid Cancer

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Cabozantinib
Sponsor:Eli Lilly & Co.

Contact Research Centre

Other cities in France

The busiest research cities in the country

All 382 cities in France

Clinical research in Bouches-du-Rhône

What the registry says about research in the country

01 Thyroid Cancer Research

Innovative clinical trials focusing on RET-mutant medullary thyroid cancer, exploring targeted therapeutic approaches for patients with advanced stages of the disease.

Advanced Treatment Comparisons
Targeted Therapy Evaluation
Progressive Disease Management

The research aims to evaluate treatment effectiveness in patients with progressive thyroid conditions, comparing different kinase inhibitor therapies to determine optimal treatment pathways.

Back to France All countries